Japan's Shift From Process to Product Patents in the Pharmaceutical Industry: An Event Study of the Impact on Japanese Firms
Sumner La Croix () and
No 199201, Working Papers from University of Hawaii at Manoa, Department of Economics
In 1976 Japan expanded the scope of its patent law by extending coverage to newly-developed chemical and pharmaceutical products. Previously the patent law had only provided protection to new production processes for manufacturing chemicals and pharmaceuticals. We use rate of return data from the Tokyo Stock Exchange for Japanese pharmaceutical companies to determine whether these firms gained from the introduction of pharmaceutical product patents. Using two different methodologies we find that the stock price for a portfolio of pharmaceutical firms and for individual firms significantly increased in response to the passage of the 1975 patent law.
Pages: 25 pages
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (1) Track citations by RSS feed
Downloads: (external link)
Journal Article: Japan's Shift from Process to Product Patents in the Pharmaceutical Industry: An Event Study of the Impact on Japanese Firms (1995)
Working Paper: Japan's Shift From Process to Product Patents in the Pharmaceutical Industry: An Event Study of the Impact on Japanese Firms (1991)
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
Persistent link: https://EconPapers.repec.org/RePEc:hai:wpaper:199201
Ordering information: This working paper can be ordered from
http://www.economics ... esearch/working.html
Access Statistics for this paper
More papers in Working Papers from University of Hawaii at Manoa, Department of Economics Contact information at EDIRC.
Bibliographic data for series maintained by Web Technician ().